Insider · CIK 0001706399

Chimovits Erez

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001706399

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director	CConversion	+513K sh	—	—	8,974,061
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director	CConversion	+1.33M sh	—	—	8,460,994
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director	CConversion	+7.13M sh	—	—	7,127,019
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−256K sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B-1 Preferred StockC Conversion	Director	CConversion	−513K sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−1.33M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−7.13M sh	—	—	0
2026-09-28	ADRXADARx Pharmaceuticals, Inc.P Purchase	Director	PPurchase	+61.5K sh	$17.00	+$1.05M	9,292,025
2026-09-28	ADRXADARx Pharmaceuticals, Inc.C Conversion	Director	CConversion	+256K sh	—	—	9,230,509
2026-08-07	BRVEBraveheart Bio, Inc. · Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−40M sh	—	—	0
2026-08-07	BRVEBraveheart Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.67M sh	$18.00	+$30M	11,901,826
2026-08-07	BRVEBraveheart Bio, Inc.C Conversion	Director, 10% Owner	CConversion	+9.13M sh	—	—	10,235,159
2026-08-07	BRVEBraveheart Bio, Inc.P Purchase	Director, 10% Owner	PPurchase	+273K sh	$18.00	+$4.92M	273,333
2026-08-05	BRVEBraveheart Bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2026-06-09	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2025-06-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2024-10-15	UPBUpstream Bio, Inc.C Conversion	Director	CConversion	+2.89M sh	—	—	3,894,873
2024-10-15	UPBUpstream Bio, Inc.C Conversion	Director	CConversion	+722K sh	—	—	973,716
2024-10-15	UPBUpstream Bio, Inc.P Purchase	Director	PPurchase	+165K sh	$17.00	+$2.81M	1,138,716
2024-10-15	UPBUpstream Bio, Inc. · Series A redeemable convertible preferred stockC Conversion	Director	CConversion	−2.1M sh	—	—	0
2024-10-15	UPBUpstream Bio, Inc. · Series A redeemable convertible preferred stockC Conversion	Director	CConversion	−525K sh	—	—	0
2024-10-15	UPBUpstream Bio, Inc.P Purchase	Director	PPurchase	+660K sh	$17.00	+$11.2M	4,554,873
2024-10-15	UPBUpstream Bio, Inc. · Series B redeemable convertible preferred stockC Conversion	Director	CConversion	−790K sh	—	—	0
2024-10-15	UPBUpstream Bio, Inc. · Series B redeemable convertible preferred stockC Conversion	Director	CConversion	−197K sh	—	—	0
2024-10-10	UPBUpstream Bio, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,096
2021-02-12	ACETAdicet Bio, Inc.A Award	Director, 10% Owner	AAward	+104K sh	$13.00	+$1.35M	396,657
2021-02-12	ACETAdicet Bio, Inc.A Award	Director, 10% Owner	AAward	+420K sh	$13.00	+$5.46M	5,243,259
2020-10-01	LogicBio Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+639K sh	$6.00	+$3.84M	4,126,972
2020-10-01	LogicBio Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+546K sh	$6.00	+$3.28M	3,524,997
2020-10-01	LogicBio Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+296K sh	$6.00	+$1.78M	296,296
2020-09-17	ACETAdicet Bio, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+30K sh	—	—	30,000
2020-09-15	ACETAdicet Bio, Inc.A Award	Director, 10% Owner	AAward	+903K sh	—	—	902,855
2020-09-15	ACETAdicet Bio, Inc.A Award	Director, 10% Owner	AAward	+293K sh	—	—	292,607
2020-06-19	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000
2020-06-19	LogicBio Therapeutics, Inc.Restricted Stock UnitsA Award	Director, 10% Owner	AAward	+2,513 sh	—	—	2,513
2020-03-25	HLSQTessera Defense & Homeland Security Inc. · Common Stock Options - Right to BuyA Award	10% Owner	AAward	+16K sh	—	—	16,000
2020-01-14	ELDNEledon Pharmaceuticals, Inc. · Warrants to Purchase Common StockS Sale	Director, 10% Owner	SSale	+646K sh	$0.20	+$129K	0
2020-01-14	ELDNEledon Pharmaceuticals, Inc. · Warrants to Purchase Common StockS Sale	Director, 10% Owner	SSale	+646K sh	$0.20	+$129K	0
2019-12-19	LogicBio Therapeutics, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	+10.9K sh	—	—	10,869
2019-12-19	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+3,500 sh	$8.90	+$31.2K	2,313,489
2019-12-18	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+500 sh	$8.93	+$4,465	2,309,989
2019-12-11	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+5,400 sh	$8.92	+$48.2K	2,309,489
2019-12-10	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+3,400 sh	$8.75	+$29.8K	2,304,089
2019-12-09	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+6,000 sh	$8.68	+$52.1K	2,300,689
2019-12-06	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+800 sh	$8.00	+$6,400	2,294,689
2019-12-05	HLSQTessera Defense & Homeland Security Inc.P Purchase	10% Owner	PPurchase	+3,400 sh	$7.99	+$27.2K	2,293,889
2019-07-11	ELDNEledon Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2019-05-02	ELDNEledon Pharmaceuticals, Inc. · Warrants to Purchase Common StockP Purchase	Director, 10% Owner	PPurchase	+646K sh	—	—	646,204
2019-05-02	ELDNEledon Pharmaceuticals, Inc. · Warrants to Purchase Common StockP Purchase	Director, 10% Owner	PPurchase	+646K sh	—	—	646,204
2019-05-02	ELDNEledon Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+646K sh	$3.10	+$2M	3,183,314

Recent filings

Accepted (ET)
Sep 304
Chimovits Erez0000947871-26-000912
SEC(opens sec.gov)
Aug 114
Chimovits Erez0000947871-26-000783
SEC(opens sec.gov)
Aug 74
Chimovits Erez0001470831-26-000802
SEC(opens sec.gov)
Jun 114
Chimovits Erez0001193125-26-268164
SEC(opens sec.gov)
Jun 124
Chimovits Erez0000950170-25-085371
SEC(opens sec.gov)
Oct 174
Chimovits Erez0000947871-24-000807
SEC(opens sec.gov)

Companies

Address

C/O ADARX PHARMACEUTICALS, INC. 5871 OBERLIN DRIVE, SUITE 200

SAN DIEGO, CA, 92121